Aprepitant and Mcp drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aprepitant (aprepitant) and Mcp (pectin). Common drug interactions include leukopenia among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Aprepitant and Mcp. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Aprepitant?

Aprepitant has active ingredients of aprepitant. eHealthMe is studying from 6,992 Aprepitant users. Check the latest studies of Aprepitant.

What is Mcp?

Mcp has active ingredients of pectin. eHealthMe is studying from 2,077 Mcp users. Check the latest studies of Mcp.

On Jul, 07, 2026

27 people who take Aprepitant and Mcp together, and have interactions are studied.

What are the common drug interactions of Aprepitant and Mcp, by gender? *:

female:

Leukopenia (less number of white blood cells in blood)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Electrolyte imbalance
Guillain-barre syndrome (the body's immune system attacks its peripheral nervous system)
Febrile neutropenia (fever with reduced white blood cells)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Vomiting
Blood thyroid stimulating hormone decreased
Cholecystitis (infection of gallbladder)
Atypical pneumonia (acute respiratory disease marked by high fever and coughing)

male:

Anaemia (lack of blood)
Hypersensitivity
General physical health deterioration (weak health status)
Urinary tract infection
Diarrhoea
Platelet count decreased
Pulmonary sepsis (pus in lungs)
Vomiting
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the common drug interactions of Aprepitant and Mcp, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Cholecystitis (infection of gallbladder)
Febrile neutropenia (fever with reduced white blood cells)
General physical health deterioration (weak health status)

40-49:

Febrile neutropenia (fever with reduced white blood cells)

50-59:

Anaemia (lack of blood)
Hypersensitivity
Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs)
Plasma cell myeloma (cancer that begins in plasma cells)
Thrombocytopenia (decrease of platelets in blood)
Vomiting

60+:

General physical health deterioration (weak health status)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Platelet count decreased
Pulmonary sepsis (pus in lungs)
Vomiting
Hip fracture
Electrolyte imbalance
Guillain-barre syndrome (the body's immune system attacks its peripheral nervous system)
Leukopenia (less number of white blood cells in blood)
Anaemia (lack of blood)

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 13 people, 48.15%
Pain: 12 people, 44.44%
Nausea And Vomiting: 8 people, 29.63%
Abdominal Pain: 8 people, 29.63%
General Physical Health Deterioration (weak health status): 7 people, 25.93%
Influenza Like Illness: 7 people, 25.93%
Ovarian Cancer (cancer of ovary): 6 people, 22.22%
Guillain-Barre Syndrome (the body's immune system attacks its peripheral nervous system): 6 people, 22.22%
High Blood Pressure: 4 people, 14.81%
Infection: 3 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Aprepitant and Mcp?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously